tiprankstipranks
Trending News
More News >
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS

Aclaris Therapeutics (ACRS) Revenue

Compare
874 Followers

Aclaris Therapeutics Revenue

Aclaris Therapeutics had a revenue of 3.30M in the quarter ending Sep 30, 2025, with 85.65%. This bring the company's revenue in the last twelve months to 15.74M, Increased -6.24%. In the fiscal year ending Dec 31, 2024, Aclaris Therapeutics had annual revenue of 18.72M with -40.09% growth.
Revenue (ttm)
15.74M
Revenue Growth
-41.87%
P/S Ratio
17.59
Revenue/Employee
$306,885
Employees
61
Market Cap
$329.37M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
18.72M-12.53M+59.91%
Dec 31, 2023
31.25M1.50M+105.03%
Dec 31, 2022
29.75M22.99M+440.05%
Dec 31, 2021
6.76M279.00K+104.30%
Dec 31, 2020
6.48M2.25M+153.35%
Dec 31, 2019
4.23M-5.86M+41.89%
Dec 31, 2018
10.09M8.41M+599.58%
Dec 31, 2017
1.68M-168,300,000.00%
Dec 31, 2016